Alzheimer's & Dementia·7 OctThe value of timely treatment with anti-amyloid therapy for Alzheimer's diseaseComputational studyInterventionsPaper
Alzheimer's & Dementia·22 SepResearch satisfaction among participants in a preclinical Alzheimer's disease trialTrial in peoplePopulationsPaper
Nature Medicine·17 SepSex-specific biological aging clocks across organs and omicsStudy in peopleBiomarkersPaper
Translational Psychiatry·16 SepRegional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer's diseaseStudy in peopleMechanismsPaper
Alzheimer's & Dementia·9 SepMore efficient screening for preclinical Alzheimer's clinical trials using mixture of expertsTrial in peopleAlzheimer's diseasePaper
Neurology·26 AugEOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic BiomarkerStudy in peopleBiomarkersPaper
Nature Mental Health·6 AugMulti-organ AI endophenotypes chart the heterogeneity of brain, eye and heart pan-diseaseStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·9 JanThe BEYONDD Project: Preliminary Findings within a Community‐Based SampleStudy in peoplePopulationsPaper
AAIC 2025 Abstract·25 DecParticipant satisfaction in a preclinical Alzheimer's disease trialTrial in peoplePopulationsPaper
AAIC 2025 Abstract·25 DecBaseline predictions of PACC progression trajectories in preclinical AD improve the precision and power of treatment effect assessmentsTrial in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecWhole blood gene expression associations with cognitive declineTrial in peopleMechanismsPaper
AAIC 2025 Abstract·24 DecWhole Blood Gene Expression Network Expression Strongly Relates to Plasma pTau217 LevelsStudy in peopleMechanismsPaper
AAIC 2025 Abstract·24 DecX‐linked gene expression is associated with plasma p ‐tau217 levels via Aβ‐PET and sex in cognitively unimpaired older adultsStudy in peopleMechanismsPaper
AAIC 2025 Abstract·23 DecDivergent latent classes of cognitive decline in the A4 and LEARN studiesComputational studyPopulationsPaper
AAIC 2025 Abstract·23 DecVariations in Plasma p ‐tau217 by Sociodemographic Factors Across World Regions in a Preclinical AD Clinical Trials Program: the AHEAD 3‐45 StudyTrial in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecA comparison of four fully automated platforms for the measurement of plasma p ‐tau217 in the Alzheimer’s disease continuumStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecAlzheimer's Disease (AD) Progression and Healthcare Resource Utilization (HRU) in Preclinical ADTrial in peoplePopulationsPaper